216 related articles for article (PubMed ID: 17245806)
1. A [meso-tetrakis(4-sulfonatophenyl)porphyrinato]zinc(ii) complex as an oral therapeutic for the treatment of type 2 diabetic KKA(y) mice.
Saha TK; Yoshikawa Y; Sakurai H
ChemMedChem; 2007 Feb; 2(2):218-25. PubMed ID: 17245806
[TBL] [Abstract][Full Text] [Related]
2. A Zinc(II)/poly(gamma-glutamic acid) complex as an oral therapeutic for the treatment of type-2 diabetic KKAy mice.
Karmaker S; Saha TK; Yoshikawa Y; Sakurai H
Macromol Biosci; 2009 Mar; 9(3):279-86. PubMed ID: 18989849
[TBL] [Abstract][Full Text] [Related]
3. A new type of orally active anti-diabetic Zn(II)-dithiocarbamate complex.
Yoshikawa Y; Adachi Y; Sakurai H
Life Sci; 2007 Jan; 80(8):759-66. PubMed ID: 17137606
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of a zinc complex improves type 2 diabetes and metabolic syndromes.
Adachi Y; Yoshida J; Kodera Y; Kiss T; Jakusch T; Enyedy EA; Yoshikawa Y; Sakurai H
Biochem Biophys Res Commun; 2006 Dec; 351(1):165-70. PubMed ID: 17052688
[TBL] [Abstract][Full Text] [Related]
5. The pharmacology of the insulinomimetic effect of zinc complexes.
Sakurai H; Adachi Y
Biometals; 2005 Aug; 18(4):319-23. PubMed ID: 16158223
[TBL] [Abstract][Full Text] [Related]
6. Improvement of hyperglycaemia and metabolic syndromes in type 2 diabetic KKAy mice by oral treatment with [meso-tetrakis(4-sulfonatophenyl) porphyrinato]oxovanadium(IV)(4-) complex.
Saha TK; Yoshikawa Y; Sakurai H
J Pharm Pharmacol; 2007 Mar; 59(3):437-44. PubMed ID: 17331348
[TBL] [Abstract][Full Text] [Related]
7. A family of insulinomimetic zinc(II) complexes of amino ligands with Zn(Nn) (n=3 and 4) coordination modes.
Yoshikawa Y; Kondo M; Sakurai H; Kojima Y
J Inorg Biochem; 2005 Jul; 99(7):1497-503. PubMed ID: 15921760
[TBL] [Abstract][Full Text] [Related]
8. A new insulin-mimetic bis(allixinato)zinc(II) complex: structure-activity relationship of zinc(II) complexes.
Adachi Y; Yoshida J; Kodera Y; Kato A; Yoshikawa Y; Kojima Y; Sakurai H
J Biol Inorg Chem; 2004 Oct; 9(7):885-93. PubMed ID: 15378407
[TBL] [Abstract][Full Text] [Related]
9. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of hyperglycemia and metabolic syndromes in type 2 diabetic KKA(y) mice by poly(gamma-glutamic acid)oxovanadium(IV) complex.
Karmaker S; Saha TK; Yoshikawa Y; Sakurai H
ChemMedChem; 2007 Nov; 2(11):1607-12. PubMed ID: 17768733
[TBL] [Abstract][Full Text] [Related]
11. Improvement of diabetes, obesity and hypertension in type 2 diabetic KKAy mice by bis(allixinato)oxovanadium(IV) complex.
Adachi Y; Yoshikawa Y; Yoshida J; Kodera Y; Katoh A; Takada J; Sakurai H
Biochem Biophys Res Commun; 2006 Jul; 345(3):945-50. PubMed ID: 16707105
[TBL] [Abstract][Full Text] [Related]
12. Insulinomimetic bis(maltolato)zinc(II) complex: blood glucose normalizing effect in KK-A(y) mice with type 2 diabetes mellitus.
Yoshikawa Y; Ueda E; Miyake H; Sakurai H; Kojima Y
Biochem Biophys Res Commun; 2001 Mar; 281(5):1190-3. PubMed ID: 11243860
[TBL] [Abstract][Full Text] [Related]
13. Development of new insulinomimetic zinc(II) picolinate complexes with a Zn(N2O2) coordination mode: structure characterization, in vitro, and in vivo studies.
Yoshikawa Y; Ueda E; Kawabe K; Miyake H; Takino T; Sakurai H; Kojima Y
J Biol Inorg Chem; 2002 Jan; 7(1-2):68-73. PubMed ID: 11862542
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of insulin-mimetic activities of vanadyl and zinc(II) complexes from the viewpoint of heterocyclic bidentate ligands.
Katoh A; Matsumura Y; Yoshikawa Y; Yasui H; Sakurai H
J Inorg Biochem; 2009 Apr; 103(4):567-74. PubMed ID: 19162327
[TBL] [Abstract][Full Text] [Related]
15. A novel drug delivery system for type 1 diabetes: insulin-mimetic vanadyl-poly(gamma-glutamic acid) complex.
Karmaker S; Saha TK; Yoshikawa Y; Yasui H; Sakurai H
J Inorg Biochem; 2006 Sep; 100(9):1535-46. PubMed ID: 16824605
[TBL] [Abstract][Full Text] [Related]
16. Blood glucose lowering and toxicological effects of zinc (II) complexes with maltol, threonine, and picolinic acid.
Kojima Y; Yoshikawa Y; Ueda E; Kondo M; Takahashi S; Matsukura T; Sakurai H; Hiroi T; Imaoka S; Funae Y
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):91-104. PubMed ID: 15080500
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of Bis(aspirinato)zinc(II) complex ameliorates hyperglycemia and metabolic syndrome-like disorders in spontaneously diabetic KK-A(y) mice: structure-activity relationship on zinc-salicylate complexes.
Yoshikawa Y; Adachi Y; Yasui H; Hattori M; Sakurai H
Chem Pharm Bull (Tokyo); 2011; 59(8):972-7. PubMed ID: 21804241
[TBL] [Abstract][Full Text] [Related]
18. Antidiabetic activity of the orally effective vanadyl-poly (gamma-glutamic acid) complex in streptozotocin(STZ)-induced type 1 diabetic mice.
Karmaker S; Saha TK; Sakurai H
J Biomater Appl; 2008 Mar; 22(5):449-64. PubMed ID: 17494957
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological and pharmacokinetic studies of anti-diabetic tropolonato-Zn(II) complexes with Zn(S(2)O(2)) coordination mode.
Murakami H; Yasui H; Yoshikawa Y
Chem Pharm Bull (Tokyo); 2012; 60(9):1096-104. PubMed ID: 22976316
[TBL] [Abstract][Full Text] [Related]
20. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
